Volume 10, Issue 1, Pages (January 2015)

Slides:



Advertisements
Similar presentations
Volume 25, Issue 2, Pages (August 2006)
Advertisements

Volume 133, Issue 4, Pages (October 2007)
Volume 40, Issue 1, Pages (January 2014)
Exacerbated colitis associated with elevated levels of activated CD4+ T cells in TCRα chain transgenic mice  Immo Prinz, Uwe Klemm, Stefan H.E. Kaufmann,
Volume 31, Issue 3, Pages (September 2009)
Volume 138, Issue 4, Pages (April 2010)
Volume 39, Issue 2, Pages (August 2013)
Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice  Eran Elinav, Tova Waks, Zelig Eshhar 
Volume 134, Issue 2, Pages (February 2008)
Volume 25, Issue 4, Pages (April 2014)
Volume 15, Issue 2, Pages (February 2009)
Volume 42, Issue 5, Pages (May 2015)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 24, Issue 5, Pages (November 2013)
Volume 29, Issue 6, Pages (December 2008)
Volume 18, Issue 1, Pages (July 2015)
Sarita Sehra, Ana P. M. Serezani, Jesus A. Ocaña, Jeffrey B
Volume 126, Issue 4, Pages (April 2004)
Volume 28, Issue 2, Pages (February 2008)
Volume 40, Issue 1, Pages (January 2014)
Volume 118, Issue 3, Pages (August 2004)
Yosuke Kamimura, Lewis L. Lanier  Cell Reports 
Volume 21, Issue 4, Pages (October 2017)
Volume 17, Issue 12, Pages (December 2016)
Cross-Differentiation from the CD8 Lineage to CD4 T Cells in the Gut-Associated Microenvironment with a Nonessential Role of Microbiota  Jen Bon Lui,
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 143, Issue 3, Pages e2 (September 2012)
Volume 22, Issue 7, Pages (February 2018)
Volume 143, Issue 1, Pages (July 2012)
Volume 24, Issue 3, Pages (March 2006)
Volume 42, Issue 4, Pages (April 2015)
Volume 132, Issue 1, Pages (January 2007)
Volume 36, Issue 2, Pages (February 2012)
Volume 29, Issue 6, Pages (December 2008)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 34, Issue 4, Pages (April 2011)
Volume 19, Issue 13, Pages (June 2017)
Volume 146, Issue 7, Pages e4 (June 2014)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Volume 135, Issue 5, Pages e5 (November 2008)
Volume 27, Issue 4, Pages (October 2007)
Volume 13, Issue 6, Pages (December 2000)
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 128, Issue 4, Pages (April 2005)
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses  Guangxun Meng, Fuping Zhang, Ivan Fuss,
Volume 40, Issue 1, Pages (January 2014)
Volume 27, Issue 3, Pages (September 2007)
Volume 20, Issue 13, Pages (September 2017)
Leptin: A pivotal mediator of intestinal inflammation in mice
Volume 16, Issue 2, Pages (February 2002)
Natural IgE Production in the Absence of MHC Class II Cognate Help
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Volume 21, Issue 4, Pages (October 2017)
Volume 41, Issue 4, Pages (October 2014)
Volume 35, Issue 2, Pages (August 2011)
Volume 41, Issue 4, Pages (October 2014)
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Volume 37, Issue 5, Pages (November 2012)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Sarita Sehra, Ana P. M. Serezani, Jesus A. Ocaña, Jeffrey B
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 34, Issue 3, Pages (March 2011)
Volume 28, Issue 5, Pages (May 2008)
Volume 131, Issue 6, Pages (December 2006)
Volume 25, Issue 11, Pages e6 (December 2018)
Induction of Lethal Graft-versus-Host Disease by Anti-CD137 Monoclonal Antibody in Mice Prone to Chronic Graft-versus-Host Disease  Wonyoung Kim, Juyang.
Volume 31, Issue 6, Pages (December 2009)
Volume 37, Issue 2, Pages (August 2012)
Volume 45, Issue 5, Pages (November 2016)
Presentation transcript:

Volume 10, Issue 1, Pages 39-46 (January 2015) The Thymus-Specific Serine Protease TSSP/PRSS16 Is Crucial for the Antitumoral Role of CD4+ T Cells  Lydie Brisson, Laurent Pouyet, Prudence N’guessan, Stéphane Garcia, Noëlla Lopes, Gilles Warcollier, Juan L. Iovanna, Alice Carrier  Cell Reports  Volume 10, Issue 1, Pages 39-46 (January 2015) DOI: 10.1016/j.celrep.2014.12.009 Copyright © 2015 The Authors Terms and Conditions

Cell Reports 2015 10, 39-46DOI: (10.1016/j.celrep.2014.12.009) Copyright © 2015 The Authors Terms and Conditions

Figure 1 TSSP Deficiency Favors CAC Tumorigenesis Cohorts of 8- to 10-week-old WT and TSSP-deficient mice (n = 36 and 24, respectively) were treated with a single injection of AOM, followed by three cycles of DSS (2.5% during 5 days, except 2% during 4 days in the last cycle) in drinking water to induce a moderate, long-lasting colitis. (A) Scheme of the CAC (AOM DSS) protocol. Colons are collected 10 weeks after injection of AOM and analyzed for the presence of tumors. (B) Mean number ± SD of tumors and their size distribution per colon from WT and TSSP-deficient (KO) animals (∗∗p < 0.01). (C) Mean ± SD of the weight-to-length ratios of the colons (mg/mm). The dashed line corresponds to the mean weight-to-length ratio of control animals (∗∗∗p < 0.001). The total number of animals is combined from three independent experiments, and data are representative of two different experiments. (D and E) Overview of hematoxylin and eosin-stained sections of representative colons from WT (D) and TSSP-deficient mice (E). Representative tumors are shown for each genotype. Scale bar corresponds to 100 μm. Cell Reports 2015 10, 39-46DOI: (10.1016/j.celrep.2014.12.009) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Absence of TSSP Increases Severity of DSS-Induced Acute Colitis Cohorts of 8- to 10-week-old mice were given 3.5% DSS in their drinking water for 7 days (gray bar) to induce acute colitis and then tap water without DSS up to the end of the experiment. (A) Weight loss is expressed as a percentage of the initial weight at day 0. TSSP-deficient mice (KO, full symbol, n = 14) lost more weight than WT mice (empty symbol, n = 18). (B) Survival curve showing a higher mortality after induction of colitis in TSSP-deficient than in WT mice. (C) The disease activity index (mean ± SD) increased to higher values in TSSP-deficient mice than in WT mice. For (A) and (C), from one to three; asterisks indicate p values of 0.05, 0.01, and 0.001, respectively, when comparing TSSP-deficient and WT mice. (D and E) Microscopic examination of colon sections 7 days after the induction of colitis shows more extensive ulceration (indicated by the black line) in TSSP-deficient animals (E) than in WT mice (D). (F and G) Histological analysis at higher magnification (×200) shows moderate epithelium damage in WT mice, with a progressive disappearance of glands (F). Damage is more severe in TSSP-deficient animals (G). Data are representative of three independent experiments. Cell Reports 2015 10, 39-46DOI: (10.1016/j.celrep.2014.12.009) Copyright © 2015 The Authors Terms and Conditions

Figure 3 T Cells Play a Key Role in Increased CAC in the Absence of TSSP The impact of TSSP deficiency on T lymphocytes during CAC development was evaluated in CD3ε-deficient mice (CD3 KO) lacking T lymphocytes. (A and B) CAC tumors mean number ± SD and size distribution per colon depending on mice genotype (n = 21–36). (A) Difference between TSSP-deficient and WT mice is abolished in a T lymphocyte-deficient background (∗ and $, compared to WT and TSSP KO, respectively). DKO, double KO. (B) Adoptive transfer of T lymphocytes isolated from WT or TSSP-deficient mice in CD3 KO recipient mice (n = 16 for each group). The difference between the two genotypes is recovered upon adoptive transfer of T lymphocytes (∗, compared to noninjected CD3 KO; $, compared to CD3 KO injected with WT T lymphocytes). (C) Expression of cytokines (mean ± SD) in total tumoral colons was evaluated by quantitative RT-PCR and compared between TSSP-deficient and WT mice on a CD3 WT background (left) or a CD3 KO background (middle) and in CD3 KO mice injected with T lymphocytes (right). From one to three, marks indicate p values less than 0.05, 0.01, and 0.001, respectively. Data are representative of independent experiments (six for A and two for B). (D and E) Adoptive transfer of mix of CD4+ and CD8+ T lymphocytes isolated from WT or TSSP-deficient mice in CD3 KO recipient mice (n = 7–16). (D) CAC tumor mean number ± SD and size distribution per colon depending on the T cell genotype. ∗ and $, compared to CD3 KO noninjected mice or CD3 KO recipient mice injected with WT T cells, respectively. (E) Cytokine expression (mean ± SD) profile in total tumoral colons from adoptively transferred CD3 KO recipient mice. The absence of TSSP in CD4 compartment induces a robust increase in IL-17A expression independently of CD8 genotype, either WT (left) or TSSP deficient (right). ∗Difference between WT and TSSP-deficient cells. Data are representative of three independent experiments. Cell Reports 2015 10, 39-46DOI: (10.1016/j.celrep.2014.12.009) Copyright © 2015 The Authors Terms and Conditions

Figure 4 Inhibition of IL-17A Cytokine Rescues the Phenotype of TSSP-Deficient Mice Impact of IL-17A has been evaluated by the injection of either control isotype or blocking anti-IL-17A antibody during the course of CAC development. (A) CAC tumor mean number ± SD and size distribution per colon depending on mice genotype and antibody injection (n = 5–9). Differences between TSSP-deficient and WT mice are almost completely abolished when mice are injected with anti-IL-17A antibody. ∗, $, and £, compared to control WT, control TSSP KO, and anti-IL-17A-treated WT mice, respectively. (B) Expression of cytokines (mean ± SD) in sane and tumoral regions of colons was evaluated by quantitative RT-PCR and compared between TSSP-deficient and WT mice injected with either control or anti-IL-17A antibody. From one to three, marks indicate p values less than 0.05, 0.01, and 0.001, respectively. (C) Immune cell percentages (mean ± SD) in secondary lymphoid organs evaluated by flow cytometry. Except for splenic Tregs (∗p < 0.05), no differences were observed between WT and TSSP-deficient mice. Data are representative of two independent experiments. Cell Reports 2015 10, 39-46DOI: (10.1016/j.celrep.2014.12.009) Copyright © 2015 The Authors Terms and Conditions